跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Perdinus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Perdinus
Approved
STANDARD
Perdinus
Serum Institute of India Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ae64d43b2b323697
Company
Serum Institute of India Private Limited
Type
Standard
Approval Details
Approval Id
ae64d43b2b323697
Drug Approval Philippines Name
Perdinus
Product Name
Perdinus
Registration Number
BR-324
Brand Name
Perdinus
Generic Name
Diphtheria-Tetanus Toxoids And Pertussis ( DTP ) Vaccines
Dosage Form
Suspension for Injection (IM) (Monodose)
Dosage Strength
30 IU (25 Lf) / 40 IU (5 Lf) / 4 IU per 0.5 mL
Manufacturer
Serum Institute of India Private Limited
Importer
Genpharm, Inc.
Distributor
Genpharm, Inc.
Company Detail Path
/organization/serum-institute-of-india-private-limited
Issuance Date
26 February 2021
Expiry Date
28 December 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ae64d43b2b323697
Type
Standard
Back to Philippines FDA Approvals